B

Baroness Merron (Lab)

Speaking in the House of Lords on 22 October 2026

Debate

Hormone Replacement Therapy: Product Shortage

Contribution

I recognise that uncertainty can affect somebody’s emotional and physical well-being. That is why it is important to use the opportunity—I am grateful to my noble friend—to give reassurance about the contained scale of this. On the point about supply resilience, which is indeed what we are working on, we set out our actions last year to improve shortage management and strengthen supply chains. We have also taken forward work to strengthen UK medicines manufacturing, to improve our understanding of supply chains and, importantly, to identify potential risks earlier. I can assure my noble friend that we will be publishing an update later this year.

More from Baroness Merron (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.